药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Bromo-2,5-dimethoxyamphetamine
Lorcainide
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Lorcainide.
4-Bromo-2,5-dimethoxyamphetamine
Bunaftine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Bunaftine.
4-Bromo-2,5-dimethoxyamphetamine
Nizofenone
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Nizofenone.
4-Bromo-2,5-dimethoxyamphetamine
Otilonium
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Otilonium.
4-Bromo-2,5-dimethoxyamphetamine
Sultopride
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Sultopride.
4-Bromo-2,5-dimethoxyamphetamine
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Sitafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Oxatomide
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Oxatomide.
4-Bromo-2,5-dimethoxyamphetamine
Abexinostat
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Abexinostat.
4-Bromo-2,5-dimethoxyamphetamine
Mizolastine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Mizolastine.
4-Bromo-2,5-dimethoxyamphetamine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ricolinostat.
4-Bromo-2,5-dimethoxyamphetamine
Simendan
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Simendan.
4-Bromo-2,5-dimethoxyamphetamine
CUDC-101
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with CUDC-101.
4-Bromo-2,5-dimethoxyamphetamine
Entinostat
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Entinostat.
4-Bromo-2,5-dimethoxyamphetamine
Mocetinostat
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Mocetinostat.
4-Bromo-2,5-dimethoxyamphetamine
Amifampridine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Amifampridine.
4-Bromo-2,5-dimethoxyamphetamine
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Dexchlorpheniramine maleate.
4-Bromo-2,5-dimethoxyamphetamine
Benidipine
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Benidipine.
4-Bromo-2,5-dimethoxyamphetamine
Melperone
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Melperone.
4-Bromo-2,5-dimethoxyamphetamine
Butriptyline
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Butriptyline.
4-Bromo-2,5-dimethoxyamphetamine
Eperisone
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Eperisone.